Origins of cardiac dysfunction in cirrhosis.
作者信息
Jiménez W, Arroyo V
机构信息
Hormonal Laboratory, Hospital Clinic, University of Barcelona, Spain.
出版信息
Gut. 2003 Oct;52(10):1392-4. doi: 10.1136/gut.52.10.1392.
Abstract
摘要
相似文献
1
Origins of cardiac dysfunction in cirrhosis.肝硬化中心脏功能障碍的起源。
Gut. 2003 Oct;52(10):1392-4. doi: 10.1136/gut.52.10.1392.
2
BNP as marker of heart dysfunction in patients with liver cirrhosis.脑钠肽作为肝硬化患者心功能障碍的标志物。
Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1331-6. doi: 10.1097/MEG.0b013e32833e6b2a.
3
Natriuretic peptides--relevance in cardiovascular disease.利钠肽——在心血管疾病中的相关性
JAMA. 1998 Dec 16;280(23):1983-4. doi: 10.1001/jama.280.23.1983.
4
Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?脑钠肽：它是肝硬化心肌病的预测指标吗？
Clin Sci (Lond). 2001 Dec;101(6):621-8.
5
Biochemical assessment of cardiac function in patients undergoing surgery for gastric cancer.接受胃癌手术患者心脏功能的生化评估
J Nippon Med Sch. 2001 Aug;68(4):351-2. doi: 10.1272/jnms.68.351.
6
7
Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.利钠肽：生物活性、潜在治疗用途及在心血管疾病中的意义的最新进展
Am J Hypertens. 2008 Jul;21(7):733-41. doi: 10.1038/ajh.2008.174. Epub 2008 May 8.
8
9
Cardiac and systemic haemodynamic complications of liver cirrhosis.肝硬化的心脏和全身血流动力学并发症
Scand Cardiovasc J. 2009 Aug;43(4):218-25. doi: 10.1080/14017430802691528.
10
Pathophysiology of sodium retention and ascites formation in cirrhosis: role of atrial natriuretic factor.
Semin Liver Dis. 1994 Feb;14(1):59-70. doi: 10.1055/s-2007-1007298.
引用本文的文献
1
Cirrhotic cardiomyopathy: a cardiologist's perspective.肝硬化性心肌病：心脏病专家的观点。
World J Gastroenterol. 2014 Nov 14;20(42):15492-8. doi: 10.3748/wjg.v20.i42.15492.
2
Liver cirrhosis and arterial hypertension.肝硬化和动脉高血压。
World J Gastroenterol. 2006 Feb 7;12(5):678-85. doi: 10.3748/wjg.v12.i5.678.
3
Hypertension and liver disease.高血压与肝脏疾病。
Curr Hypertens Rep. 2004 Dec;6(6):453-61. doi: 10.1007/s11906-004-0041-5.
本文引用的文献
1
2
Brain natriuretic peptide: role in cardiovascular and volume homeostasis.脑钠肽：在心血管和容量稳态中的作用。
Semin Nephrol. 2002 Sep;22(5):423-37. doi: 10.1053/snep.2002.35666.
3
4
Hepatorenal syndrome in cirrhosis: pathogenesis and treatment.肝硬化中的肝肾综合征：发病机制与治疗
Gastroenterology. 2002 May;122(6):1658-76. doi: 10.1053/gast.2002.33575.
5
Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.肝硬化性心肌病：肝病循环功能障碍的病理生理学综述
Heart. 2002 Jan;87(1):9-15. doi: 10.1136/heart.87.1.9.
6
Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?脑钠肽：它是肝硬化心肌病的预测指标吗？
Clin Sci (Lond). 2001 Dec;101(6):621-8.
7
Is there a cirrhotic cardiomyopathy?是否存在肝硬化性心肌病？
Am J Gastroenterol. 2000 Nov;95(11):3026-8. doi: 10.1111/j.1572-0241.2000.03249.x.
8
Cardiac excitation-contraction coupling in the portal hypertensive rat.门脉高压大鼠的心脏兴奋-收缩偶联
Am J Physiol Gastrointest Liver Physiol. 2000 Jul;279(1):G28-39. doi: 10.1152/ajpgi.2000.279.1.G28.
9
Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.肝硬化的并发症。II. 肾脏与循环功能障碍。一个重要临床问题中的光明与阴影
J Hepatol. 2000;32(1 Suppl):157-70. doi: 10.1016/s0168-8278(00)80423-7.
10
Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites.
Hepatology. 1999 Dec;30(6):1387-92. doi: 10.1002/hep.510300613.
Zotero 插件